Abstract—We have compared the antitumor activity of aurumacryl, a new cancer drug, and several well-known cytostatics with different mechanisms of action, that is, cisplatin, cyclophosphan, 5-fluorouracil, and doxorubicin, on experimental murine solid tumor models: Lewis lung carcinoma and Acatol adenocarcinoma. Aurumacryl is more active than the listed cytostatics except for cyclophosphan. Aurumacryl inhibits the growth of Lewis lung carcinoma and Acatol adenocarcinoma by 70 and 74%, respectively, compared to the control.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
D. B. Korman, Fudamentals of Antitumor Chemotherapy (Prakticheskaya Meditsina, Moscow, 2006) [in Russian].
A. Markowska, B. Kospzak, K. Jaszczynska-Nowinka, et al., Comtemp. Oncol. (Pozn.). 19, 271 (2015).
M. Frezza, S. Hindo, D. Chen, et al., Curr. Pharm. Des. 16, 1813 (2010).
C. Nardon and D. Fregona, Curr. Top. Med. Chem. 16, 360 (2016).
S. Nobili, E. Mini, I. Landini, et al., Med. Res. Rev. 30, 580 (2010).
D. B. Korman, L. A. Ostrovskaya, and V. A. Kuz’min, Vopr. Onkol. 64 (6), 697 (2018).
D. B. Korman, L. A. Ostrovskaya, and V. A. Kuz’min, Biophysics (Moscow) 64 (3), 431 (2019).
L. A. Ostrovskaya, M. G. Voronkov, D. B. Korman, et al., J. Cancer Ther. 1 (2), 59 (2010).
L. A. Ostrovskaya, D. B. Korman, and N. V. Bluhterova, Biointerface Res. Appl. Chem. 4 (4), 816 (2014).
L. A. Ostrovskaya, M. G. Voronkov, D. B. Korman, et al., Biophysics (Moscow) 59 (4), 642 (2014).
L. A. Ostrovskaya, D. B. Korman, A. K. Grekhova, et al., Izv. Ross. Akad. Nauk, Ser. Khim., No. 12, 2333 (2017).
E. M. Treshchalina, O. S. Zhukova, G. K. Gerasimova, et al., in Guidelines for Conducting Preclinical Trials of Medicines, Ed. by A. N. Mironov et al. (Grif i K, Moscow, 2012), Part 1, pp. 642–657 [in Russian].
L. A. Ostrovskaya, S. D. Varfolomeev, M. G. Voronkov, et al., Izv. Ross. Akad. Nauk, Ser. Khim., No. 5, 1211 (2014).
L. A. Ostrovskaya, D. B. Korman, N. V. Blyukhterova, et al., Khim. Fiz. 38 (12), 64 (2019).
D. B. Korman, E. I. Nekrasova, L.A. Ostrovskaya, et al., Biophysics (Moscow) 64 (6), 930 (2019).
D. Saggioro, M. P. Rigobello, L. Paloschi, et al., Chem. Biol. 14, 128 (2007).
L. Ronconi, D. Aldinucci, Q. P. Don, and D. Fregona, Anticancer Agents Med. Chem. 10, 283 (2010).
A. Casini and L. Messori, Curr. Top. Med. Chem. 11, 2647 (2011).
B. I. Zapadinskii, A. V. Kotova, I. A. Matveeva, et al., Khim. Fiz. 29 (10), 87 (2010).
N. A. Plate and A. E. Vasil’ev, Physiologically Active Polymers (Khimiya, Moscow, 1986) [in Russian].
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interests. The authors declare that they have no conflict of interest.
Statement on the welfare of animals. All applicable international, national, and/or institutional guidelines for the care and use of animals were followed.
Additional information
Translated by V. Gulevich
Rights and permissions
About this article
Cite this article
Ostrovskaya, L.A., Korman, D.B., Bluhterova, N.V. et al. Experimental Comparison of the Antitumor Activities of Aurumacryl and Cytostatics with Different Mechanisms of Action. BIOPHYSICS 65, 313–318 (2020). https://doi.org/10.1134/S0006350920020177
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0006350920020177